TipRanks
Cellectar Biosciences (DE:NV40)
FRANKFURT:NV40
Germany Market
NV40
Cellectar Biosciences
RESEARCH TOOLSreports

Cellectar Biosciences (NV40) Income Statement

1 Followers

Cellectar Biosciences Income Statement

Last quarter (Q2 2026), Cellectar Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Cellectar Biosciences's net income was $-6.93M. See Cellectar Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -213.60K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 22.77M$ 51.78M$ 38.96M$ 28.81M$ 24.13M
Depreciation and Amortization
$ 213.60K$ 291.65K$ 192.38K$ 148.44K$ 149.91K
EBITDA
$ -21.58M$ -44.22M$ -42.64M$ -31.70M$ -23.97M
Operating Income
$ -22.98M$ -51.78M$ -38.96M$ -28.81M$ -24.13M
Other Income/Expenses
$ 1.19M$ 7.26M$ -3.87M$ -3.04M$ 8.92K
Pretax Income
$ -21.79M$ -44.52M$ -42.83M$ -31.85M$ -24.12M
Net Income
$ -21.79M$ -44.58M$ -42.77M$ -31.79M$ -24.12M
Per Share Metrics
Basic EPS
$ -8.35$ -36.52$ -104.99$ -135.18$ -130.35
Diluted EPS
$ -8.35$ -41.89$ -104.99$ -135.18$ -130.35
Weighted Average Shares Outstanding
 2.61M 1.22M 407.38K 235.19K 185.05K
Weighted Average Shares Outstanding (Diluted)
 2.61M 1.24M 407.38K 235.19K 185.05K
Currency in USD

Cellectar Biosciences Earnings and Revenue History